Ashleigh Acker
About Ashleigh Acker
Ashleigh Acker is a Biotechnology Equity Research Associate at Piper Sandler in Chicago, Illinois, where she has worked since 2023. She holds a Bachelor of Science in Biology from Emory University and a Master of Science in Biotechnology from Northwestern University.
Work at Piper Sandler
Ashleigh Acker serves as a Biotechnology Equity Research Associate at Piper Sandler, a position she has held since 2023. Based in Chicago, Illinois, she focuses on analyzing biotechnology companies and providing insights to support investment decisions. Her role involves evaluating market trends, financial performance, and scientific developments within the biotechnology sector.
Education and Expertise
Ashleigh Acker holds a Bachelor of Science in Biology/Biological Sciences from Emory University, where she studied from 2017 to 2021. She furthered her education by obtaining a Master of Science in Biotechnology from Northwestern University, completing her studies in 2023. Her academic background provides a strong foundation for her work in biotechnology equity research.
Background
Before joining Piper Sandler, Ashleigh Acker gained diverse experience in the biotechnology field. She worked as a Commercial Business Associate at Evozyne for two months in 2021 and held various roles, including Graduate Researcher at the Chemistry of Life Processes Institute in 2023 and Business Analyst Intern at BioHealth Innovation, Inc. in 2023. Her previous positions have contributed to her comprehensive understanding of the biotechnology landscape.
Previous Experience in Biotechnology
Ashleigh Acker has held several positions in the biotechnology sector prior to her current role. In 2022, she worked as a Strategy Co-Op at Senda Biosciences in Cambridge, Massachusetts, and as a Venture Capital Analyst at Gen 1 Capital in Chicago. Additionally, she served as a Graduate Nano-Fabrication Research Intern at Acorn Genetics for six months. These experiences have equipped her with a broad perspective on the industry.